Abstract: The present invention relates to: an amorphous of spherical embolisation hydrogel having a degradation time that can be precisely controlled in blood vessels; and a preparation method therefor.

Abstract: The present invention relates to the field of perfumery. More particularly, it concerns a consumer product comprising at least one compound of formula (I) and, optionally, a personal care active base. Moreover, the present invention relates to a method of imparting a long-lasting odor, in particular green odor, to surfaces, such as skin or hair.

Abstract: Provided are compositions and methods for reducing pre-existing antibodies against viral vector or gene-editing related proteins. The compositions showed reduction in various antibody titers by administration of a liposome composition complexed with a protein or fragment thereof of a viral vector. The liposomes comprise phosphatidylcholine and phosphatidylserine, wherein some or all of the PS is present as lyso-PS. The compositions and methods can be used in conjunction with gene therapy and nucleic acid based vector based vaccinations and therapeutics.

Abstract: A film-forming composition for skin, including components (A) and (B): (A) a silicone-based film-forming agent; and (B) a fiber having an average fiber diameter of 0.1 ?m or more and 7 ?m or less in an amount of 0.05 mass % or more and 2 mass % or less relative to the whole film-forming composition. A mass ratio of the component (B) to the component (A), (B/A), is 0.05 or more and 1 or less.

Abstract: The present invention relates to oral films containing an active pharmaceutical ingredient (API) capable of providing seizure relief and one or more film-forming polymers, the use of such films, for example for the acute treatment of ongoing seizures, and methods for preparing such films. The film according to the invention is characterized by a rapid dissolution in the buccal cavity followed by a rapid and high systemic absorption.

Abstract: The present invention relates to the use of native and/or porous starch as white pigment in dental health products and in particular in toothpastes. The present invention also relates to the process of fabricating a dental health product composition and in particular a toothpaste composition.

Abstract: The use of nanometric liposome-like (chitosomes) in pharmaceutical or cosmetic composition and a preparation thereof with the chitosomes including chitosan molecules, phospholipid molecules, a cross-linking agent and at least one active pharmaceutical or cosmetic ingredient.

Abstract: The present invention relates to conditioning cosmetic compositions comprising, in a cosmetically acceptable aqueous medium, non-ionic surfactants and cationic polymers. In particular, these compositions are reserved for applications to hair with or without rinsing. In addition, the compositions concern methods of repair, protection, and improvement of hair properties. Additionally, the present invention relates to cosmetic products comprising such cosmetic compositions, such as shampoos, conditioners and hair treatment products, as well as the use thereof.

Abstract: The present invention refers to a dry composition for chemical and physical sun protection, the composition comprising at least one mineral material selected from the group consisting of surface reacted calcium carbonate and/or hydromagnesite, and from 0.1 wt.-% to 100 wt.-%, based on the dry weight of the at least one mineral material of at least one lignin. Furthermore, the present invention refers to an emulsion comprising the inventive dry composition as well as the use of the inventive emulsion for chemical and physical sun protection in a cosmetic formulation.

Abstract: The present invention provides new storable and stable disinfectant compositions comprising use of a solid precursor of an oxidized state of chlorine. The component in the device is devoid of stability issues, since the solid precursors are instantly to be dissolved in water or a pharmaceutically acceptable diluent, adjuvant, or carrier, and combined with an activator, e.g. adipic or succinic acid or their salts, optionally combined with a viscosity enhancer, optionally combined with a dye. The main product according to the invention is generated by dissolving effervescent material in the form of tablets or granules, the resulting solutions from dissolution of the effervescent material are useful disinfectants for treating a broad spectrum of pathogenic bacterial and/or viral, fungal, or parasitic pathogens, denoted microbials.

Abstract: An encapsulated bacteriophage formulation and a method for encapsulating bacteriophages and bacteriophage-related products in polymeric microcapsules is provided. Some embodiments of the method of producing the encapsulated bacteriophages involves a water-in-oil-in-water double emulsion.

Abstract: The present invention relates to a photoprotective composition comprising, in a physiologically acceptable medium, at least one photoprotective compound and a surfactant comprising at least one ester derivative or amide derivative of glycine betaine. It also relates to the cosmetic use of this photoprotective composition for protecting the skin against certain effects of UVA radiation, and also to this photoprotective composition for use thereof in the protection of the skin against erythema caused by UVB radiation. Finally, it relates to the use of the abovementioned surfactant for increasing the sand resistance of a photoprotective composition.

Abstract: Disclosed herein are synthetic nanoparticles, pharmaceutical compositions, kits, or methods for treating and/or preventing cancer. In some embodiments, the synthetic nanoparticles and/or pharmaceutical compositions comprises a pH sensitive liposome, an apolipoprotein, and andrographolide or derivative thereof. In some embodiments, the synthetic nanoparticles are delivered to a subject for treatment of cancer. In some embodiments, the cancer is T-cell lymphoma or B-cell lymphoma.

Abstract: Disclosed herein is a non-flowable and deformable hemostatic compositions comprised of a xerogel crosslinked powdered polysaccharide dispersed within a substantially anhydrous blend of: glycerol, and polyethylene glycol (PEG), wherein the PEG and glycerol are present in a ratio ranging from higher than 1:1.3: to below 1:2.7 by weight, respectively, and wherein the powder content in the composition is above 50%, by weight. Methods of making the non-flowable compositions, and uses of the compositions in methods for treating a wound or a bleeding tissue, such as bone tissue, are further disclosed.

Abstract: A sunscreen composition includes a sunscreen active, a carrier, and a film former polymer. The sunscreen active may be selected from organic sunscreen actives. The carrier may include an amphiphile monolayer to encapsulate a least a portion of the total amount of the sunscreen active. The film former polymer may include an acrylic film former polymer selected from C1-C30 alkyl (meth)acrylates copolymer. Notably, the sunscreen active may provide enhanced photoprotection at relatively low concentration levels when present with the carrier, including the amphiphile monolayer, and the acrylic film former polymer.

Abstract: The present invention relates to a sponge dressing for treating wounds comprised of a polymer sponge containing a plurality of antimicrobial dyes with at least one dye being gram positive and at least one other dye being gram negative and a silicon adhesive secured to a sponge surface. The sponge dressing can be exposed initially to gamma radiation and later sterilized by ethylene oxide or alternatively it can be sterilized by ethylene oxide and later irradiated by gamma radiation. The sponge dressing has a morphology characterized by an average pore throat diameter of 0.5-500 ?m and a porosity ranging from about 60% to about 99.5%. The sponge dressing can also contain at least one biofilm reducing agent, at least one chelating agent and an ionic and non-ionic surfactant.

Abstract: A self nanoemulsion drug delivery system (SNEDDS) may include a 10% quercetin SNEDD oil mixture including quercetin, oleic acid, castor oil and polyethylene glycol. The system also includes a microfluidized nanoliposomal solution including sunflower lecithin, glycerin and water. The oil mixture and nanoliposomal solution are combined to create a SNEDDS. The SNEEDS has a composition of about 1.00% by weight of quercetin and about 15.0% by weight of sunflower lecithin.

Abstract: The present invention concerns a composition, in particular a cosmetic composition, comprising, in a physiologically acceptable aqueous medium: at least one clay selected from phyllosilicates having a 2:1 layered structure, at least one crystallizable fat, and at least one liposoluble filter capable of absorbing UVA and/or UVB.

Abstract: The present invention is a bake type cosmetic composition, and resolves issues of stability, shrinkage of content, loss of effective components, etc., which occur due to the conventional hot-air drying process, and is finer on a surface and enables the creation of various designs.

Abstract: A solid dosage form for oral transmucosal delivery of an active pharmaceutical ingredient (API) is disclosed. Also provided are methods of treating a disease with the solid dosage form.